ADAPTIMMUNE TRANSFORMING T CELL THERAPY Trademark

Trademark Overview


On Wednesday, October 14, 2015, a trademark application was filed for ADAPTIMMUNE TRANSFORMING T CELL THERAPY with the United States Patent and Trademark Office. The USPTO has given the ADAPTIMMUNE TRANSFORMING T CELL THERAPY trademark a serial number of 79178123. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, October 7, 2023. This trademark is owned by Adaptimmune Limited. The ADAPTIMMUNE TRANSFORMING T CELL THERAPY trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases via T cell therapy

Medical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient
adaptimmune transforming t cell therapy

General Information


Serial Number79178123
Word MarkADAPTIMMUNE TRANSFORMING T CELL THERAPY
Filing DateWednesday, October 14, 2015
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, October 7, 2023
Registration Number5163514
Registration DateTuesday, March 21, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 3, 2017

Trademark Statements


Description of MarkThe mark consists of a stylized circular design and the words "ADAPTIMMUNE TRANSFORMING T CELL THERAPY".
Goods and ServicesPharmaceutical preparations for the treatment of cancer and autoimmune diseases via T cell therapy
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient
Disclaimer with Predetermined Text"T CELL THERAPY"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 14, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 14, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptimmune Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAbingdon Oxfordshire OX14 4RX
GB

Party NameAdaptimmune Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAdaptimmune Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Saturday, October 7, 2023NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, October 7, 2023REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Saturday, October 7, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 20, 2023TEAS SECTION 71 & 15 RECEIVED
Monday, March 21, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, November 2, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, July 21, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 29, 2017FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 29, 2017FINAL DISPOSITION PROCESSED
Wednesday, June 21, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 21, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, January 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2017PUBLISHED FOR OPPOSITION
Friday, December 30, 2016NOTIFICATION PROCESSED BY IB
Wednesday, December 14, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 14, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 23, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 23, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, November 23, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 23, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, November 23, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, May 27, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 27, 2016NON-FINAL ACTION E-MAILED
Friday, May 27, 2016NON-FINAL ACTION WRITTEN
Thursday, May 12, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, April 12, 2016WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, March 25, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 27, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 4, 2016REFUSAL PROCESSED BY IB
Wednesday, February 17, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 17, 2016REFUSAL PROCESSED BY MPU
Sunday, February 14, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, February 13, 2016NON-FINAL ACTION WRITTEN
Thursday, February 4, 2016ASSIGNED TO EXAMINER
Friday, December 18, 2015APPLICATION FILING RECEIPT MAILED
Monday, December 14, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 10, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB